Globus Medical, Inc.
GMED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $7,703 | $7,980 | $10,011 | $11,309 |
| - Cash | $372 | $229 | $461 | $784 |
| + Debt | $119 | $121 | $92 | $537 |
| Enterprise Value | $7,451 | $7,871 | $9,642 | $11,062 |
| Revenue | $769 | $745 | $598 | $657 |
| % Growth | 3.2% | 24.6% | -9% | – |
| Gross Profit | $487 | $497 | $403 | $394 |
| % Margin | 63.3% | 66.6% | 67.3% | 59.9% |
| EBITDA | $215 | $193 | $164 | $145 |
| % Margin | 28% | 26% | 27.4% | 22.1% |
| Net Income | $119 | $203 | $75 | $27 |
| % Margin | 15.5% | 27.2% | 12.6% | 4% |
| EPS Diluted | 0.88 | 1.49 | 0.54 | 0.19 |
| % Growth | -40.9% | 175.9% | 184.2% | – |
| Operating Cash Flow | $250 | $78 | $177 | $210 |
| Capital Expenditures | -$31 | -$47 | -$41 | -$17 |
| Free Cash Flow | $219 | $31 | $136 | $193 |